Global Immuno-Oncology Treatment Market Status and Outlook 2024-2029
Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight the disease. It is an application of the fundamental research of cancer immunology and a growing subspeciality of oncology.
Our market research covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2029 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets.
We can meet the customized needs of customers in multiple dimensions, in-depth and high quality, help customers accurately grasp market opportunities, easily deal with market challenges, properly formulate market strategies, and act quickly to win sufficient market competition time and space for customers.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
The global economy and markets have been remarkably resilient in the face of tightening financial conditions and geopolitical upheaval over the past few years, with economic growth holding up better than most analysts’ expectations.
The global environment has still not settled onto a clear pathway toward a new stability as we enter 2024. In this disjointed world, we confront risks posed by potential volatility across the economic and political spheres. We also see potential opportunities arising from the new reality of greatly segmented global relationships.
We have identified five overlapping themes that will drive global political and economic relationships in 2024: geopolitical reordering, economic fault lines, resource security, supply chain resilience and logistics rewired.
The report will conduct a comprehensive and professional analysis of the Immuno-Oncology Treatment market in 2024 based on the current situation, global economic impact and other aspects.
Market Segment by Product Type
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Market Segment by Product Application
Hospitals
Ambulatory Surgical Center
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Amgen
Merck
Eli-Lilly
AstraZeneca
Janssen Biotech
Bristol-Myers Squibb
Pfizer
GlaxoSmithKline
Roche
Novartis
Sanofi
Spectrum Pharmaceuticals
Takeda
Insights and Tools:
This report provides industry-standard analytical accuracy and high data completeness to uncover key opportunities available in the global industry market. Buyers of the report can obtain verified and reliable market forecasts, including revenue forecasts for the overall size of the global industry market.
The report is an effective tool for players to gain a competitive advantage over their competitors and ensure lasting success in the industry market. All findings, data, and information presented in the report have been verified and re-verified with the help of reliable sources. The analysts who authored the report have taken a unique approach to industry-best research and analysis for an in-depth study of the global industry market.
Use both primary and secondary data sources when compiling reports. Primary sources include extensive interviews with key opinion leaders and industry experts such as experienced front-line employees, directors, CEOs and marketing executives, downstream distributors as well as end users. Secondary sources include research on top companies' annual and financial reports, public documents, new journals, and more. We also work with some third-party databases.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
1.To define, describe and forecast the Immuno-Oncology Treatment market by type, application, end user and region
2.Provide enterprise external environment analysis and SWOT analysis
3.Focuses on the key global Immuno-Oncology Treatment manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, and development plans in next few years.
4.Provide market entry strategy analysis for new players or players preparing to enter the market
5.Keep up with international market trends and analyze the impact of the important international events on major global regions
6.Analyze market opportunities for stakeholders to provide market leaders with detailed information on the competitive landscape
Global Immuno-Oncology Treatment Market Status and Outlook 2024-2029
Market Study Overview
1.1 Study Objectives
1.2 Immuno-Oncology Treatment Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Immuno-Oncology Treatment Segment by Type
2.1.1 Immune Checkpoint Inhibitors
2.1.2 Monoclonal Antibodies
2.1.3 Cytokine-Based Immunotherapy
2.1.4 Cancer Vaccines
2.1.5 CAR-T Cell Therapy
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Ambulatory Surgical Center
2.2.3 Others
2.3 Global Immuno-Oncology Treatment Market Comparison by Regions (2019-2029)
2.3.1 Global Immuno-Oncology Treatment Market Size (2019-2029)
2.3.2 North America Immuno-Oncology Treatment Status and Prospect (2019-2029)
2.3.3 Europe Immuno-Oncology Treatment Status and Prospect (2019-2029)
2.3.4 Asia-pacific Immuno-Oncology Treatment Status and Prospect (2019-2029)
2.3.5 South America Immuno-Oncology Treatment Status and Prospect (2019-2029)
2.3.6 Middle East & Africa Immuno-Oncology Treatment Status and Prospect (2019-2029)
2.5 Coronavirus Disease 2020 (Covid-19): Immuno-Oncology Treatment Industry Impact
2.5.1 Immuno-Oncology Treatment Business Impact Assessment - Covid-19
2.5.2 Market Trends and Immuno-Oncology Treatment Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Vendors
3.1 Global Immuno-Oncology Treatment Revenue and Market Share by Vendors (2019-2024)
3.2 Global Immuno-Oncology Treatment Industry Concentration Ratio (CR5 and HHI)
3.3 Top 5 Immuno-Oncology Treatment Vendors Market Share
3.4 Top 10 Immuno-Oncology Treatment Vendors Market Share
3.5 Date of Key Vendors Enter into Immuno-Oncology Treatment Market
3.6 Key Vendors Immuno-Oncology Treatment Product Offered
3.7 Mergers & Acquisitions Planning
4 Analysis of Immuno-Oncology Treatment Industry Key Vendors
4.1 Amgen
4.1.1 Company Details
4.1.2 Product Introduction, Application and Specification
4.1.3 Amgen Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.1.4 Main Business Overview
4.1.5 Amgen News
4.2 Merck
4.2.1 Company Details
4.2.2 Product Introduction, Application and Specification
4.2.3 Merck Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.2.4 Main Business Overview
4.2.5 Merck News
4.3 Eli-Lilly
4.3.1 Company Details
4.3.2 Product Introduction, Application and Specification
4.3.3 Eli-Lilly Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.3.4 Main Business Overview
4.3.5 Eli-Lilly News
4.4 AstraZeneca
4.4.1 Company Details
4.4.2 Product Introduction, Application and Specification
4.4.3 AstraZeneca Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.4.4 Main Business Overview
4.4.5 AstraZeneca News
4.5 Janssen Biotech
4.5.1 Company Details
4.5.2 Product Introduction, Application and Specification
4.5.3 Janssen Biotech Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.5.4 Main Business Overview
4.5.5 Janssen Biotech News
4.6 Bristol-Myers Squibb
4.6.1 Company Details
4.6.2 Product Introduction, Application and Specification
4.6.3 Bristol-Myers Squibb Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.6.4 Main Business Overview
4.6.5 Bristol-Myers Squibb News
4.7 Pfizer
4.7.1 Company Details
4.7.2 Product Introduction, Application and Specification
4.7.3 Pfizer Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.7.4 Main Business Overview
4.7.5 Pfizer News
4.8 GlaxoSmithKline
4.8.1 Company Details
4.8.2 Product Introduction, Application and Specification
4.8.3 GlaxoSmithKline Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.8.4 Main Business Overview
4.8.5 GlaxoSmithKline News
4.9 Roche
4.9.1 Company Details
4.9.2 Product Introduction, Application and Specification
4.9.3 Roche Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.9.4 Main Business Overview
4.9.5 Roche News
4.10 Novartis
4.10.1 Company Details
4.10.2 Product Introduction, Application and Specification
4.10.3 Novartis Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.10.4 Main Business Overview
4.10.5 Novartis News
4.11 Sanofi
4.11.1 Company Details
4.11.2 Product Introduction, Application and Specification
4.11.3 Sanofi Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.11.4 Main Business Overview
4.11.5 Sanofi News
4.12 Spectrum Pharmaceuticals
4.12.1 Company Details
4.12.2 Product Introduction, Application and Specification
4.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.12.4 Main Business Overview
4.12.5 Spectrum Pharmaceuticals News
4.13 Takeda
4.13.1 Company Details
4.13.2 Product Introduction, Application and Specification
4.13.3 Takeda Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.13.4 Main Business Overview
4.13.5 Takeda News
5 Global Immuno-Oncology Treatment Market Size Categorized by Regions
5.1 Global Immuno-Oncology Treatment Revenue and Market Share by Regions
5.2 North America Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
5.3 Europe Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
5.4 Asia-pacific Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
5.5 South America Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
5.6 Middle East & Africa Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
6 North America Immuno-Oncology Treatment Market Size Categorized by Countries
6.1 North America Immuno-Oncology Treatment Revenue and Market Share by Countries
6.1.1 North America Immuno-Oncology Treatment Market Size by Countries (2019-2024)
6.1.2 United States Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
6.1.3 Canada Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
6.1.4 Mexico Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
6.2 North America Immuno-Oncology Treatment Revenue (Value) by Vendors
6.3 North America Immuno-Oncology Treatment Revenue and Market Share by Type (2019-2024)
6.4 North America Immuno-Oncology Treatment Revenue and Market Share by Application (2019-2024)
7 Europe Immuno-Oncology Treatment Market Size Categorized by Countries
7.1 Europe Immuno-Oncology Treatment Revenue and Market Share by Countries
7.1.1 Europe Immuno-Oncology Treatment Market Size by Countries (2019-2024)
7.1.2 Germany Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
7.1.3 UK Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
7.1.4 France Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
7.1.5 Russia Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
7.1.6 Italy Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
7.1.7 Spain Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
7.2 Europe Immuno-Oncology Treatment Revenue (Value) by Vendors
7.3 Europe Immuno-Oncology Treatment Revenue and Market Share by Type (2019-2024)
7.4 Europe Immuno-Oncology Treatment Revenue and Market Share by Application (2019-2024)
8 Asia-pacific Immuno-Oncology Treatment Market Size Categorized by Countries
8.1 Asia-pacific Immuno-Oncology Treatment Revenue and Market Share by Countries
8.1.1 Asia-pacific Immuno-Oncology Treatment Market Size by Countries (2019-2024)
8.1.2 China Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
8.1.3 South Korea Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
8.1.4 Japan Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
8.1.5 Australia Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
8.1.6 India Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
8.1.7 Southeast Asia Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
8.2 Asia-pacific Immuno-Oncology Treatment Revenue (Value) by Vendors
8.3 Asia-pacific Immuno-Oncology Treatment Revenue and Market Share by Type (2019-2024)
8.4 Asia-pacific Immuno-Oncology Treatment Revenue and Market Share by Application (2019-2024)
9 South America Immuno-Oncology Treatment Market Size Categorized by Countries
9.1 South America Immuno-Oncology Treatment Revenue and Market Share by Countries
9.1.1 South America Immuno-Oncology Treatment Market Size by Countries (2019-2024)
9.1.2 Brazil Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
9.1.3 Chile Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
9.2 South America Immuno-Oncology Treatment Revenue and Market Share by Type (2019-2024)
9.3 South America Immuno-Oncology Treatment Revenue and Market Share by Application (2019-2024)
10 Middle East and Africa Immuno-Oncology Treatment Market Size Categorized by Countries
10.1 Middle East and Africa Immuno-Oncology Treatment Revenue and Market Share by Countries
10.1.1 Middle East and Africa Immuno-Oncology Treatment Market Size by Countries (2019-2024)
10.1.2 GCC Countries Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
10.1.3 Turkey Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
10.1.4 Egypt Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
10.1.5 South Africa Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
10.2 Middle East and Africa Immuno-Oncology Treatment Revenue and Market Share by Type
10.3 Middle East and Africa Immuno-Oncology Treatment Revenue Market Share by Application (2019-2024)
11 Global Immuno-Oncology Treatment Market Segment by Type
11.1 Global Immuno-Oncology Treatment Revenue and Market Share by Type (2019-2024)
11.2 Immune Checkpoint Inhibitors Revenue Growth Rate and Price
11.3 Monoclonal Antibodies Revenue Growth Rate and Price
11.4 Cytokine-Based Immunotherapy Revenue Growth Rate and Price
11.5 Cancer Vaccines Revenue Growth Rate and Price
11.6 CAR-T Cell Therapy Revenue Growth Rate and Price
12 Global Immuno-Oncology Treatment Market Segment by Application
12.1 Global Immuno-Oncology Treatment Revenue Market Share by Application (2019-2024)
12.2 Hospitals Revenue Growth Rate (2019-2024)
12.3 Ambulatory Surgical Center Revenue Growth Rate (2019-2024)
12.4 Others Revenue Growth Rate (2019-2024)
13 Global Immuno-Oncology Treatment Market Forecast
13.1 Global Immuno-Oncology Treatment Revenue and Growth Rate (2024-2029)
13.2 Immuno-Oncology Treatment Market Forecast by Regions (2024-2029)
13.2.1 North America Immuno-Oncology Treatment Market Forecast (2024-2029)
13.2.2 Europe Immuno-Oncology Treatment Market Forecast (2024-2029)
13.2.3 Asia-Pacific Immuno-Oncology Treatment Market Forecast (2024-2029)
13.2.4 South America Immuno-Oncology Treatment Market Forecast (2024-2029)
13.2.5 Middle East & Africa Immuno-Oncology Treatment Market Forecast (2024-2029)
13.3 Immuno-Oncology Treatment Market Forecast by Type (2024-2029)
13.3.1 Global Immuno-Oncology Treatment Revenue Forecast by Type (2024-2029)
13.3.2 Global Immuno-Oncology Treatment Market Share Forecast by Type (2024-2029)
13.4 Immuno-Oncology Treatment Market Forecast by Application (2024-2029)
13.4.1 Global Immuno-Oncology Treatment Revenue Forecast by Application (2024-2029)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Downstream Market Analysis
15.1 Macro Analysis of Down Markets
15.2 Key Players in Down Markets
16 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Immuno-Oncology Treatment
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Immuno-Oncology Treatment Market Size (Million US$) by Type
Figure Global Market Share of Immuno-Oncology Treatment by Type in 2023
Figure Immune Checkpoint Inhibitors Picture
Figure Monoclonal Antibodies Picture
Figure Cytokine-Based Immunotherapy Picture
Figure Cancer Vaccines Picture
Figure CAR-T Cell Therapy Picture
Table Global Immuno-Oncology Treatment Market Size (Million US$) by Application
Figure Global Immuno-Oncology Treatment Market Share by Application in 2023
Figure Hospitals Picture
Figure Ambulatory Surgical Center Picture
Figure Others Picture
Table Global Immuno-Oncology Treatment Comparison by Regions (M USD) 2019-2029
Figure Global Immuno-Oncology Treatment Market Size (Million US$) (2019-2029)
Figure North America Immuno-Oncology Treatment Revenue (Million US$) Growth Rate (2019-2029)
Figure Europe Immuno-Oncology Treatment Revenue (Million US$) Growth Rate (2019-2029)
Figure Asia-pacific Immuno-Oncology Treatment Revenue (Million US$) Growth Rate (2019-2029)
Figure South America Immuno-Oncology Treatment Revenue (Million US$) Growth Rate (2019-2029)
Figure Middle East & Africa Immuno-Oncology Treatment Revenue (Million US$) Growth Rate (2019-2029)
Table Business Impact Assessment - Covid-19
Table Market Trends and Immuno-Oncology Treatment Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Immuno-Oncology Treatment Revenue by Vendors (2019-2024)
Figure Global Immuno-Oncology Treatment Revenue Market Share by Vendors in 2023
Table Global Immuno-Oncology Treatment Vendors Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Immuno-Oncology Treatment Vendors (Revenue) Market Share in 2023
Figure Top 10 Immuno-Oncology Treatment Vendors (Revenue) Market Share in 2023
Table Date of Key Vendors Enter into Immuno-Oncology Treatment Market
Table Key Vendors Immuno-Oncology Treatment Product Type
Table Amgen Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Amgen
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Amgen 2019-2024
Table Amgen Main Business
Table Amgen Recent Development
Table Merck Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Merck
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Merck 2019-2024
Table Merck Main Business
Table Merck Recent Development
Table Merck Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Merck
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Merck 2019-2024
Table Merck Main Business
Table Merck Recent Development
Table Eli-Lilly Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Eli-Lilly
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Eli-Lilly 2019-2024
Table Eli-Lilly Main Business
Table Eli-Lilly Recent Development
Table AstraZeneca Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of AstraZeneca
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of AstraZeneca 2019-2024
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Janssen Biotech Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Janssen Biotech
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Janssen Biotech 2019-2024
Table Janssen Biotech Main Business
Table Janssen Biotech Recent Development
Table Bristol-Myers Squibb Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Bristol-Myers Squibb
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2019-2024
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Pfizer Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Pfizer
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Pfizer 2019-2024
Table Pfizer Main Business
Table Pfizer Recent Development
Table GlaxoSmithKline Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of GlaxoSmithKline
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of GlaxoSmithKline 2019-2024
Table GlaxoSmithKline Main Business
Table GlaxoSmithKline Recent Development
Table Roche Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Roche
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Roche 2019-2024
Table Roche Main Business
Table Roche Recent Development
Table Novartis Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Novartis
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Novartis 2019-2024
Table Novartis Main Business
Table Novartis Recent Development
Table Sanofi Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Sanofi
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Sanofi 2019-2024
Table Sanofi Main Business
Table Sanofi Recent Development
Table Spectrum Pharmaceuticals Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Spectrum Pharmaceuticals
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Spectrum Pharmaceuticals 2019-2024
Table Spectrum Pharmaceuticals Main Business
Table Spectrum Pharmaceuticals Recent Development
Table Takeda Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Takeda
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Takeda 2019-2024
Table Takeda Main Business
Table Takeda Recent Development
Table Mergers & Acquisitions Planning
Figure Global Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Global Immuno-Oncology Treatment Revenue by Regions (2019-2024)
Figure Global Immuno-Oncology Treatment Revenue Market Share by Regions in 2023
Figure North America Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Europe Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Asia-pacific Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure South America Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Middle East & Africa Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure North America Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table North America Immuno-Oncology Treatment Market Size by Countries (2019-2024)
Table North America Immuno-Oncology Treatment Market Share by Countries (2019-2024)
Figure North America Immuno-Oncology Treatment Market Share by Countries in 2023
Figure United States Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Canada Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Mexico Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table North America Immuno-Oncology Treatment Revenue by Vendors (2023)
Figure North America Immuno-Oncology Treatment Revenue Market Share by Vendors in 2023
Table North America Immuno-Oncology Treatment Revenue by Type (2019-2024)
Table North America Immuno-Oncology Treatment Share by Type (2019-2024)
Table North America Immuno-Oncology Treatment Revenue by Application (2019-2024)
Table North America Immuno-Oncology Treatment Revenue Share by Application (2019-2024)
Figure Europe Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table Europe Immuno-Oncology Treatment Market Size by Countries (2019-2024)
Table Europe Immuno-Oncology Treatment Revenue Market Share by Countries (2019-2024)
Figure Europe Immuno-Oncology Treatment Revenue Market Share by Countries in 2023
Figure Germany Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure UK Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure France Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Russia Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Italy Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Spain Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table Europe Immuno-Oncology Treatment Revenue by Vendors (2023)
Figure Europe Immuno-Oncology Treatment Revenue Market Share by Vendors in 2023
Table Europe Immuno-Oncology Treatment Revenue by Type (2019-2024)
Table Europe Immuno-Oncology Treatment Revenue Share by Type (2019-2024)
Table Europe Immuno-Oncology Treatment Revenue by Application (2019-2024)
Table Europe Immuno-Oncology Treatment Revenue Share by Application (2019-2024)
Figure Asia-pacific Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table Asia-pacific Immuno-Oncology Treatment Market Size by Countries (2019-2024)
Table Asia-pacific Immuno-Oncology Treatment Revenue Market Share by Countries (2019-2024)
Figure Asia-pacific Immuno-Oncology Treatment Revenue Market Share by Countries in 2023
Figure China Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure South Korea Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Japan Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Australia Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure India Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Southeast Asia Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table Asia-pacific Immuno-Oncology Treatment Revenue by Vendors (2023)
Figure Asia-pacific Immuno-Oncology Treatment Revenue Market Share by Vendors in 2023
Table Asia-pacific Immuno-Oncology Treatment Revenue by Type (2019-2024)
Table Asia-pacific Immuno-Oncology Treatment Revenue Share by Type (2019-2024)
Table Asia-pacific Immuno-Oncology Treatment Revenue by Application (2019-2024)
Table Asia-pacific Immuno-Oncology Treatment Revenue Share by Application (2019-2024)
Figure South America Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table South America Immuno-Oncology Treatment Revenue Market Size by Countries (2019-2024)
Table South America Immuno-Oncology Treatment Revenue Market Share by Countries (2019-2024)
Figure South America Immuno-Oncology Treatment Revenue Market Share by Countries in 2023
Figure Brazil Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Chile Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table South America Immuno-Oncology Treatment Revenue s by Type (2019-2024)
Table South America Immuno-Oncology Treatment Revenue Share by Type (2019-2024)
Table South America Immuno-Oncology Treatment Revenue by Application (2019-2024)
Table South America Immuno-Oncology Treatment Revenue Share by Application (2019-2024)
Figure Middle East and Africa Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table Middle East and Africa Immuno-Oncology Treatment Market Size by Countries (2019-2024)
Table Middle East and Africa Immuno-Oncology Treatment Sales Market Share by Countries (2019-2024)
Figure Middle East and Africa Immuno-Oncology Treatment Sales Market Share by Countries in 2023
Figure GCC Countries Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Turkey Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Egypt Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure South Africa Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table Middle East and Africa Immuno-Oncology Treatment Revenue by Type (2019-2024)
Table Middle East and Africa Immuno-Oncology Treatment Revenue Share by Type (2019-2024)
Table Middle East and Africa Immuno-Oncology Treatment Revenue by Application (2019-2024)
Table Middle East and Africa Immuno-Oncology Treatment Revenue Share by Application (2019-2024)
Table Global Immuno-Oncology Treatment Revenue by Type (2019-2024)
Table Global Immuno-Oncology Treatment Revenue Market Share by Type (2019-2024)
Figure Global Immuno-Oncology Treatment Revenue Market Share by Type in 2023
Figure Global Immune Checkpoint Inhibitors Revenue and Growth Rate (2019-2024)
Figure Global Monoclonal Antibodies Revenue and Growth Rate (2019-2024)
Figure Global Cytokine-Based Immunotherapy Revenue and Growth Rate (2019-2024)
Figure Global Cancer Vaccines Revenue and Growth Rate (2019-2024)
Figure Global CAR-T Cell Therapy Revenue and Growth Rate (2019-2024)
Table Global Immuno-Oncology Treatment Revenue by Application (2019-2024)
Table Global Immuno-Oncology Treatment Revenue Market Share by Application (2019-2024)
Figure Global Immuno-Oncology Treatment Revenue Market Share by Application in 2023
Figure Global Hospitals Revenue Growth Rate (2019-2024)
Figure Global Ambulatory Surgical Center Revenue Growth Rate (2019-2024)
Figure Global Others Revenue Growth Rate (2019-2024)
Figure Global Immuno-Oncology Treatment Revenue and Growth Rate (2024-2029)
Table Global Immuno-Oncology Treatment Revenue Forecast by Regions (2024-2029)
Table Global Immuno-Oncology Treatment Market Share Forecast by Regions (2024-2029)
Figure North America Revenue Immuno-Oncology Treatment Market Forecast (2024-2029)
Figure Europe Revenue Immuno-Oncology Treatment Market Forecast (2024-2029)
Figure Asia-Pacific Revenue Immuno-Oncology Treatment Market Forecast (2024-2029)
Figure South America Revenue Immuno-Oncology Treatment Market Forecast (2024-2029)
Figure Middle East & Africa Revenue Immuno-Oncology Treatment Market Forecast (2024-2029)
Table Global Immuno-Oncology Treatment Revenue Forecast by Type (2024-2029)
Table Global Immuno-Oncology Treatment Market Share Forecast by Type (2024-2029)
Table Global Immuno-Oncology Treatment Revenue Forecast by Application (2024-2029)
Table Global Immuno-Oncology Treatment Market Share Forecast by Application (2024-2029)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Author List
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|